46 related articles for article (PubMed ID: 24402647)
1. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
Shen X; Zhang Y; Feng Y; Zhang L; Li J; Xie YA; Luo X
Int J Oncol; 2014 Mar; 44(3):791-6. PubMed ID: 24402647
[TBL] [Abstract][Full Text] [Related]
2. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis.
Duan ZW; Liu Y; Zhang PP; Hu JY; Mo ZX; Liu WQ; Ma X; Zhou XH; Wang XH; Hu XH; Wei SL
J Ethnopharmacol; 2024 Sep; 331():118293. PubMed ID: 38705430
[TBL] [Abstract][Full Text] [Related]
3. Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
He L; Peng L; Wang L; Jiang X; Sun X; Li H; Lin T; Wu Z; Lin S
Biochem Biophys Res Commun; 2024 Jun; 714():149976. PubMed ID: 38677007
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin Gallate Potentiates the Anticancer Effect of
Rodponthukwaji K; Pingrajai P; Jantana S; Taya S; Duangchan K; Nguyen KT; Srisawat C; Punnakitikashem P
Nanomaterials (Basel); 2023 Dec; 14(1):. PubMed ID: 38202502
[TBL] [Abstract][Full Text] [Related]
5. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma.
Li D; Cao D; Cui Y; Sun Y; Jiang J; Cao X
Front Pharmacol; 2023; 14():1201085. PubMed ID: 37292151
[TBL] [Abstract][Full Text] [Related]
6. Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs.
Yoshioka Y; Ohishi T; Nakamura Y; Fukutomi R; Miyoshi N
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744941
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Mechanism of Combined Hydroxychavicol With Epigallocatechin-3-Gallate Against Glioma Cancer Cell Lines: A Transcriptomic Analysis.
Abdul Rahman A; Wan Ngah WZ; Jamal R; Makpol S; Harun R; Mokhtar N
Front Pharmacol; 2022; 13():844199. PubMed ID: 35392560
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Antioxidant, Immunomodulatory Activity of Oxidised Epigallocatechin-3-Gallate (Green Tea Polyphenol) and Its Action on the Main Protease of SARS-CoV-2-An In Vitro and In Silico Approach.
Ungarala R; Munikumar M; Sinha SN; Kumar D; Sunder RS; Challa S
Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204178
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts.
Chen S; Nishi M; Morine Y; Shimada M; Tokunaga T; Kashihara H; Takasu C; Yamada S; Wada Y
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35029285
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A.
Tang Y; Cao J; Cai Z; An H; Li Y; Peng Y; Chen N; Luo A; Tao H; Li K
Mol Med Rep; 2020 Nov; 22(5):3873-3885. PubMed ID: 33000276
[TBL] [Abstract][Full Text] [Related]
11. ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma.
Chen J; Chen L; Lu T; Xie Y; Li C; Jia Z; Cao J
Int J Clin Exp Pathol; 2019; 12(9):3222-3234. PubMed ID: 31934166
[TBL] [Abstract][Full Text] [Related]
12. BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
Gao H; Yu G; Zhang X; Yu S; Sun Y; Li Y
J Cell Mol Med; 2019 Jun; 23(6):3905-3915. PubMed ID: 30932331
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives.
Bimonte S; Albino V; Piccirillo M; Nasto A; Molino C; Palaia R; Cascella M
Drug Des Devel Ther; 2019; 13():611-621. PubMed ID: 30858692
[TBL] [Abstract][Full Text] [Related]
14. A novel role of HuR in -Epigallocatechin-3-gallate (EGCG) induces tumour cells apoptosis.
Jian W; Fang S; Chen T; Fang J; Mo Y; Li D; Xiong S; Liu W; Song L; Shen J; Xia Y; Wang Q; Hong H
J Cell Mol Med; 2019 May; 23(5):3767-3771. PubMed ID: 30793483
[No Abstract] [Full Text] [Related]
15. DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high-glucose conditions, potentially through the SIRT1/HIF-1/VEGF pathway.
Mi DH; Fang HJ; Zheng GH; Liang XH; Ding YR; Liu X; Liu LP
CNS Neurosci Ther; 2019 Mar; 25(3):323-332. PubMed ID: 30136405
[TBL] [Abstract][Full Text] [Related]
16. EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway.
Luo KW; Lung WY; Chun-Xie ; Luo XL; Huang WR
Oncotarget; 2018 Feb; 9(15):12261-12272. PubMed ID: 29552308
[TBL] [Abstract][Full Text] [Related]
17. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases.
Li S; Tan HY; Wang N; Cheung F; Hong M; Feng Y
Oxid Med Cell Longev; 2018; 2018():8394818. PubMed ID: 29507653
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate confers protection against corticosterone-induced neuron injuries via restoring extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3 kinase/protein kinase B signaling pathways.
Zhao X; Li R; Jin H; Jin H; Wang Y; Zhang W; Wang H; Chen W
PLoS One; 2018; 13(1):e0192083. PubMed ID: 29373584
[TBL] [Abstract][Full Text] [Related]
19. Anti-Cancer Phytometabolites Targeting Cancer Stem Cells.
Torquato HF; Goettert MI; Justo GZ; Paredes-Gamero EJ
Curr Genomics; 2017 Apr; 18(2):156-174. PubMed ID: 28367074
[TBL] [Abstract][Full Text] [Related]
20. Involvement of PKCα and ERK1/2 signaling pathways in EGCG's protection against stress-induced neural injuries in Wistar rats.
Zhao X; Liu F; Jin H; Li R; Wang Y; Zhang W; Wang H; Chen W
Neuroscience; 2017 Mar; 346():226-237. PubMed ID: 28131624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
